Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,304.10
-0.80 (-0.06%)
At close: Jul 10, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 136.49 billion as of July 13, 2026. Its market cap has decreased by -33.88% in one year.
Market Cap
136.49B
Enterprise Value
132.34B
Revenue
10.55B
Ranking
n/a
PE Ratio
52.31
Stock Price
1,304.10
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 136.49B, an increase of 38.39%. That is a compound annual growth rate of 11.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 136.49B | -3.04% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 235.82B |
| Granules India | 220.43B |
| AstraZeneca Pharma India | 203.10B |
| Caplin Point Laboratories | 196.52B |
| Jubilant Pharmova | 152.20B |
| CORONA Remedies | 124.94B |
| Viyash Scientific | 121.49B |
| Procter & Gamble Health | 113.41B |